Halma announced that it acquired medical consumable device maker IZI Medical Products for $153.5 million.
Maryland-based IZI develops devices used by interventional radiologists and surgeons across acute, hospital-based diagnostic and therapeutic procedures. Its three primary markets consist of image-guided surgery, interventional oncology and interventional spine procedures.
Among IZI’s offerings is the Quick-Core Auto Biopsy System for automatic biopsies. It also develops the Kiva vertebral compression fracture (VCF) treatment system.
“Our purpose is to improve patients’ lives with physician-led innovation,” said IZI CEO Greg Groenke. “This vision aligns to Halma’s when it comes to improving quality of care delivered by healthcare providers. Many physicians started using our technologies in medical school and have continued to do so throughout their careers. Joining the Halma group will take IZI Medical Products to the next level, add…